Fighting Cancer

Every Step of the Way

Vigilant Biosciences is transforming the early detection and intervention of cancer.

Learn More
vb-homepage-image3

Dedicated to Early Intervention. And Life.


Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection and intervention of cancer. Its OncAlert™ Oral Cancer Risk Assessment System uses patented technology that is highly-accurate and specific.

Learn More
Did You Know?

When diagnosed early, oral cancer patients have an 80 to 90% survival rate.

Unfortunately, over 40% of those diagnosed with oral cancer will die within five years due to these cases being discovered as a late stage malignancy.

Learn More

At A Glance

Transforming Early Detection

Vigilant Biosciences’ products are based on patented technology that detects specific protein markers known to clinically show elevated risk for early stage cancers, even prior to observation of visual or physical symptoms... more


Easy-to-Use and Non-Invasive

OncAlert™ products utilize a simple oral rinse procedure that is easy to administer and non-invasive for the patient... more


Accurate and Objective Results at the Point-of-Care or Lab

Both the rapid point-of-care test and the lab assay that comprise the OncAlert™ system provide a timely, accurate, and specific risk assessment for oral cancer... more

MORE ABOUT VIGILANT'S ONCALERT™ TECHNOLOGY

News + Press

  • logo

    April is Oral Cancer Awareness Month

    April is Oral Cancer Awareness month. ASDA is encouraging the dental community and public to spread the word on oral cancer prevention! As oral health care professionals, we are often the first to see signs of oral cancer. Awareness and…more

  • realhealth-logo

    Say Ahhh!

    The other day I visited my dentist for a regular check-up. At one point, the dentist asked me to open my mouth wide and stick out my tongue. When I did, he grasped my tongue with a tissue, moved it…more

  • vb-400x210

    Vigilant Biosciences Announces Two Poster Presentations at the 2015 AACR Annual Meeting

    FORT LAUDERDALE, Fla. — Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today the upcoming presentation of two abstracts supporting the ongoing clinical development of its OncAlert…more

  • dentistryIQ

    Oral cancer products

    OncAlert from Vigilant Biosciences After witnessing his parents’ battles with oral cancer, Matthew H.J. Kim, JD, founded Vigilant Biosciences-a company that is soon to launch a new system of products for oral cancer risk assessment. He now heads the company…more


©2011-2015 Vigilant Biosciences, Inc. All Rights Reserved.

×